Top 10 Companies in the (S)-(-)-beta-Hydroxy-gamma-butyrolactone (CAS No. 7331-52-4) Market (2026): Market Leaders Powering Global Demand

MARKET INSIGHTS

The Global (S)-(-)-beta-Hydroxy-gamma-butyrolactone (CAS No. 7331-52-4) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a CAGR of 7.2% during the forecast period.

(S)-(-)-beta-Hydroxy-gamma-butyrolactone (CAS No. 7331-52-4) is a chiral lactone compound with the molecular formula C₄H₆O₃, widely recognized as a versatile chiral building block in asymmetric synthesis. Its high optical purity and well-defined stereochemistry make it particularly valuable in the preparation of enantiomerically enriched pharmaceuticals, agrochemicals, and fine chemical intermediates.

The market is steadily gaining momentum, primarily driven by the rising demand for chiral intermediates in pharmaceutical synthesis and the expanding scope of asymmetric catalysis in industrial chemistry. Growing emphasis on enantioselective drug development, particularly in the production of active pharmaceutical ingredients (APIs), continues to underpin demand. Furthermore, advancements in green chemistry and biocatalytic production methods are improving yields and cost‑efficiency, making the compound increasingly accessible to a broader range of end‑users across North America, Europe, and Asia‑Pacific.

(S)-(-)-beta-Hydroxy-gamma-butyrolactone (CAS No. 7331-52-4) Market – View in Detailed Research Report

🔟 1. MilliporeSigma (Merck KGaA)

Headquarters: Germany / USA
Key Offering: Research and Pharmaceutical Grade Chiral Lactones

MilliporeSigma, part of the Merck Group, is a global leader in providing high‑purity chiral reagents. Their portfolio includes (S)-(-)-beta‑hydroxy‑gamma‑butyrolactone in both research and GMP‑grade formats, supporting drug discovery, process chemistry, and fine‑chemical synthesis.

Sustainability Initiatives:

• Investment in green chemistry and solvent‑free processes.
• Carbon‑neutral supply chain goals by 2030.
• Comprehensive waste‑reduction program for chemical manufacturing.

9️⃣ 2. TCI Chemicals

Headquarters: Japan
Key Offering: Global Catalog of Chiral Intermediates

TCI Chemicals offers a broad range of chiral building blocks, including (S)-(-)-beta‑hydroxy‑gamma‑butyrolactone, with emphasis on rapid delivery and stringent quality control for pharmaceutical and fine‑chemical applications.

Sustainability Initiatives:

• Eco‑friendly synthesis routes and reduced solvent usage.
• Partnerships with universities for green chemistry research.
• ISO 14001 certification for environmental management.

8️⃣ 3. Combi-Blocks Inc.

Headquarters: USA
Key Offering: Custom Chiral Synthesis Services

Combi-Blocks specializes in on‑demand synthesis of chiral intermediates, providing tailored routes for (S)-(-)-beta‑hydroxy‑gamma‑butyrolactone with high enantiomeric excess and rapid turnaround for API developers.

Sustainability Initiatives:

• Use of renewable feedstocks in synthesis.
• Implementation of continuous flow chemistry to reduce waste.
• Carbon footprint tracking for all production batches.

7️⃣ 4. Synthonix Inc.

Headquarters: USA
Key Offering: Proprietary Chiral Catalyst Development

Synthonix focuses on developing and licensing chiral catalysts that enable efficient production of (S)-(-)-beta‑hydroxy‑gamma‑butyrolactone, targeting high‑throughput synthesis for drug discovery programs.

Sustainability Initiatives:

• Design of catalysts with lower metal loading to reduce environmental impact.
• Recycling of catalyst systems in continuous processes.
• Life‑cycle assessment of chiral catalyst production.

6️⃣ 5. Hairui Chemical Co., Ltd.

Headquarters: China
Key Offering: Bulk Production of Chiral Lactones

Hairui Chemical provides high‑volume supply of (S)-(-)-beta‑hydroxy‑gamma‑butyrolactone, leveraging advanced asymmetric synthesis platforms to meet the growing demand from the pharmaceutical and agrochemical sectors.

Sustainability Initiatives:

• Adoption of greener reagents and solvents.
• Energy‑efficient production facilities with renewable energy sources.
• Waste minimization through process optimization.

5️⃣ 6. Aladdin Biochemical Technology Co., Ltd.

Headquarters: China
Key Offering: Fine Chemical Intermediates and Catalysts

Aladdin Biochemical supplies a comprehensive range of fine chemicals, including (S)-(-)-beta‑hydroxy‑gamma‑butyrolactone, with a focus on quality assurance and regulatory compliance for API manufacturing.

Sustainability Initiatives:

• Implementation of green chemistry principles in all synthesis routes.
• Carbon‑neutral production targets by 2035.
• Collaboration with research institutions on sustainable catalyst development.

4️⃣ 7. Henan Tianfu Chemical Co., Ltd.

Headquarters: China
Key Offering: Specialty Chiral Reagents

Henan Tianfu focuses on specialty chiral reagents, offering (S)-(-)-beta‑hydroxy‑gamma‑butyrolactone with rigorous purity specifications for pharmaceutical and agrochemical applications.

Sustainability Initiatives:

• Use of renewable feedstock where possible.
• Closed‑loop recycling of by‑products.
• ISO 9001 and ISO 14001 certified manufacturing.

3️⃣ 8. Fluorochem Ltd.

Headquarters: United Kingdom
Key Offering: Advanced Fluorinated Chiral Intermediates

Fluorochem supplies fluorinated chiral intermediates and supports custom synthesis of (S)-(-)-beta‑hydroxy‑gamma‑butyrolactone for high‑value pharmaceutical projects, emphasizing high enantiomeric purity and regulatory compliance.

Sustainability Initiatives:

• Development of fluorine‑free synthetic routes.
• Reduced energy consumption in reactor operations.
• Partnerships with academia on green fluorine chemistry.

2️⃣ 9. BASF SE

Headquarters: Germany
Key Offering: Global Fine Chemical Production

BASF SE offers a broad portfolio of fine chemicals, including (S)-(-)-beta‑hydroxy‑gamma‑butyrolactone, with a strong focus on sustainability and process efficiency for API manufacturing.

Sustainability Initiatives:

• Carbon‑neutral production goals by 2030.
• Investment in renewable energy for manufacturing sites.
• Life‑cycle assessment of chiral intermediates.

1️⃣ 10. Lonza Group

Headquarters: Switzerland
Key Offering: Contract Development and Manufacturing Services (CDMO)

Lonza provides CDMO services for the pharmaceutical industry, including the synthesis and supply of (S)-(-)-beta‑hydroxy‑gamma‑butyrolactone in GMP‑grade formats, supporting end‑to‑end API development.

Sustainability Initiatives:

• Zero‑waste manufacturing targets.
• Use of renewable feedstocks in synthesis.
• Carbon‑offset programs for global operations.

Download FREE Sample Report: (S)-(-)-beta-Hydroxy-gamma-butyrolactone (CAS No. 7331-52-4) Market

Get Full Report: (S)-(-)-beta-Hydroxy-gamma-butyrolactone (CAS No. 7331-52-4) Market

🌍 Outlook: The Future of (S)-(-)-beta-Hydroxy-gamma-butyrolactone Market

The (S)-(-)-beta‑hydroxy‑gamma‑butyrolactone market is poised for sustained growth, driven by the expanding pipeline of enantiopure drug candidates and the increasing adoption of green chemistry principles in API manufacturing. Key drivers include regulatory pushes for single‑enantiomer drugs, advancements in biocatalytic synthesis, and the growing demand for chiral intermediates in agrochemical and specialty chemical sectors. Manufacturers that invest in scalable, cost‑effective production routes and maintain rigorous quality standards will capture the largest share of the market, while the niche nature of the end‑use will continue to constrain overall volume growth.

📈 Future Trends

• Rapid commercialization of engineered ketoreductases for cost‑efficient production of (S)-(-)-beta‑hydroxy‑gamma‑butyrolactone.
• Integration of continuous flow chemistry to enhance scalability and reduce waste.
• Expansion of the market into biodegradable polymer precursors and specialty materials.
• Increased collaboration between academic research and industry to discover new asymmetric catalytic methodologies.
• Greater regulatory harmonization across regions, facilitating smoother global supply chains.